Skip to main content
Clinical Trials/NCT04725513
NCT04725513
Completed
Not Applicable

Pilot Investigation to Evaluate Effectiveness of Shockwave Therapy, a Combination of Shockwave Therapy and Photobiomodulation and Physical Therapy in the Management of Non-insertional Achilles Tendinopathy: A Randomized Control Trial With Elective Cross-Over Design

Spaulding Rehabilitation Hospital1 site in 1 country46 target enrollmentAugust 29, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Achilles Tendinopathy
Sponsor
Spaulding Rehabilitation Hospital
Enrollment
46
Locations
1
Primary Endpoint
Calf Raises Performed to Fatigue and Inability to Continue
Status
Completed
Last Updated
3 months ago

Overview

Brief Summary

This is a randomized control trial with an elective cross over after three months to evaluate three different treatments in the management of non-insertional Achilles Tendinopathy. The treatment methods include physical therapy, shockwave therapy and photobiomodulation.

Detailed Description

This is a randomized control study with an elective cross over. In part 1 of the study participants will be randomized into one of three treatment arms: 1) physical therapy only; 2) physical therapy and shockwave therapy; 3) physical therapy, shockwave therapy and photobiomodulation. At 3 months, patients can choose to switch to a different treatment arm than they were initially randomized.

Registry
clinicaltrials.gov
Start Date
August 29, 2022
End Date
October 1, 2024
Last Updated
3 months ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Spaulding Rehabilitation Hospital
Responsible Party
Principal Investigator
Principal Investigator

Adam Tenforde

Principal Investigator

Spaulding Rehabilitation Hospital

Eligibility Criteria

Inclusion Criteria

  • A diagnosis of mid-portion Achilles tendinopathy (including both unilateral and bilateral)
  • Running is the pre-injury primary form of physical activity and pre-injury would complete on average 10 miles per week or more of running
  • VISA-A \<80 at baseline to be eligible

Exclusion Criteria

  • Less than 3 months of symptoms
  • Primary insertional Achilles tendinopathy
  • Diagnosis of rheumatological disease/connective tissue condition, symptomatic arthritis of foot and ankle, a primary running related injury outside Achilles tendinopathy, other contraindications to PBMT or SWT
  • Have received SWT within the past 3 months to their Achilles
  • Prior injection within 3 months
  • Currently enrolled in PT for more than 4 weeks for their condition
  • Women who are pregnant.
  • known history of Achilles tendon tear
  • currently taking oral steroid or fluoroquinolone class of antibiotics

Outcomes

Primary Outcomes

Calf Raises Performed to Fatigue and Inability to Continue

Time Frame: Difference from 0-3 months

Calf raises performed to fatigue and inability to continue

Ultrasound Measurements in Change of Cross Sectional Area

Time Frame: Difference from 0-3 months

Changes in the cross-sectional area measured on ultrasound

Victorian Institute of Sports Assessment (VISA-A) Questionnaire

Time Frame: change from baseline to 3 month follow-up measure

Victorian Institute of Sports Assessment Questionnaire. The score of the questionnaire ranges from 0-100, where 100 is a person who is completely asymptomatic (better).

Study Sites (1)

Loading locations...

Similar Trials